#USA #biopharmaceuticals #PTC Therapeutics #Warren #Health Conference

PTC Therapeutics to Showcase at Upcoming Investor Conferences

PTC Therapeutics, Inc. (NASDAQ: PTCT) is gearing up for a significant presence at several prominent healthcare conferences this March. The company's leadership team will present at multiple venues, opening a vital dialogue on advancements in biotechnology and rare disease treatment.

Upcoming Conferences:

1. TD Cowen 46th Annual Health Care Conference 2026
- Date: March 2, 2026
- Time: 9:50 a.m. ET
- This conference will serve as an excellent platform for PTC to discuss its innovative approaches to treatment for rare disorders, potentially transforming healthcare for patients in need.

2. Leerink 2026 Global Healthcare Conference
- Date: March 10, 2026
- Time: 4:20 p.m. ET
- PTC executives are expected to share insights into the company’s strategic pipeline and how they plan to meet the urgency of patient needs through clinical differentiation in their medicines.

3. Barclays Global Healthcare Conference 2026
- Date: March 11, 2026
- Time: 8:00 a.m. ET
- This conference will focus on the company's advancements and ongoing efforts to provide effective solutions for patients with unmet medical needs, showcasing PTC's commitment to innovation.

All three presentations will be available for live streaming via the Events and Presentations section on the PTC Therapeutics website. Interested stakeholders should log in a few minutes early to ensure a seamless experience. Moreover, archived versions of the presentations will be accessible for 30 days post-event, allowing for broader reach and engagement.

About PTC Therapeutics

PTC Therapeutics is recognized as a pioneer in the biopharmaceutical industry, concentrating on the discovery, development, and commercialization of treatments specifically tailored for individuals living with rare disorders. The company's mission is to create access to transformative medicines that can significantly improve the quality of life for patients with complex health conditions. PTC’s robust pipeline of medicines showcases their dedication to not only meeting but exceeding current treatment standards.

PTC harnesses its scientific expertise alongside a well-established global commercial presence, optimizing value and effectiveness for both patients and other stakeholders.

To stay updated on PTC’s activities and innovations, individuals can visit their official website at www.ptcbio.com and engage with PTC on various social media platforms including LinkedIn, X, Instagram, and Facebook.

For any further inquiries, investors can contact Ellen Cavaleri at +1 (615) 618-6228 and media representatives may reach out to Jeanine Clemente at +1 (908) 912-9406.

As PTC Therapeutics continues to push boundaries in healthcare, their upcoming presentations promise to provide invaluable insights into the future landscape of biopharmaceuticals, particularly within the realm of rare disease treatment.

Stay tuned for these pivotal conferences, as PTC aims to lead discussions that may spearhead advancements across the biopharmaceutical sector!